Should You Buy Amneal Pharmaceuticals Inc (AMRX) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
Buy (long-term). AMRX is in a clear bullish uptrend with supportive Wall Street sentiment (multiple Buy/Overweight ratings and price targets raised to ~$15). While the stock looks a bit stretched short-term (RSI elevated and price pushing above nearby resistance), a beginner long-term investor with $50k–$100k who doesn’t want to wait for a perfect entry can still buy now, preferably starting with a partial position and adding if it pulls back toward prior support.
Technical Analysis
Trend/Price Action: Bullish. Moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200), confirming an established uptrend.
Momentum: MACD histogram is positive and expanding (0.0221), supporting continued upside momentum.
RSI: RSI_6 at ~71.7 suggests the stock is nearing overbought conditions, increasing the odds of a short-term pause/pullback even within an uptrend.
Levels: Pivot 13.358. Resistance R1 13.866 and R2 14.18; pre-market price ~14.22 is slightly above R2, meaning the stock is currently testing/clearing a key resistance area. Supports at S1 12.85 and S2 12.536.
Pattern-based short-term odds: Similar-pattern analysis implies a higher probability of mild downside over the next week/month (-3% to -4% range), which aligns with the ‘stretched’ RSI/readings despite the broader uptrend.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock today.
Analyst Ratings and Price Target Trends
Recent trend: Analysts have been constructive and price targets moved upward into the $15 area. Piper Sandler lifted PT to $13 (Overweight) after a Q3 beat; Barclays initiated Overweight at $15; Truist raised PT to $15 and maintained Buy.
Wall Street pros: improving sentiment, easing sector pricing headwinds, de-leveraging/margin expansion opportunity, and a defensive ‘affordable medicines’ theme.
Wall Street cons: the business still needs clearer proof of sustained margin and earnings expansion (recent margin/net income YoY deterioration).
Influential buyers/sellers: Hedge funds and insiders show neutral trends; no recent Congress trading data available.
Wall Street analysts forecast AMRX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMRX is 13.75 USD with a low forecast of 12 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast AMRX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMRX is 13.75 USD with a low forecast of 12 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 14.110
Current: 14.110
